TrueBlue Inc (NYSE:TBI) price on Friday, March 21, fall -1.55% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $5.71.
A look at the stock’s price movement, the close in the last trading session was $5.80, moving within a range at $5.52 and $5.78. The beta value (5-Year monthly) was 1.346. Turning to its 52-week performance, $12.65 and $5.19 were the 52-week high and 52-week low respectively. Overall, TBI moved -9.79% over the past month.
TrueBlue Inc’s market cap currently stands at around $169.64 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-18.
Analysts have a consensus estimate of 362.37M for the company’s revenue for the quarter, with a low and high estimate of 361.12M and 363.7M respectively. The average forecast suggests down to a -10.05% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 1.54B, representing a -2.02% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TBI is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend TBI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TBI’s current price about -0.98% and -17.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.23, while 7-day volatility ratio is 4.13% and 5.57% in the 30-day chart. Further, TrueBlue Inc (TBI) has a beta value of 1.39, and an average true range (ATR) of 0.33. Analysts have given the company’s stock an average 52-week price target of $12.5, forecast between a low of $12 and high of $13. Looking at the price targets, the low is -110.16% off current price level while to achieve the yearly target high, price needs to move -127.67%. Nonetheless, investors will most likely welcome a -118.91% jump to $12.5 which is the analysts’ median price.
If we refocus on TrueBlue Inc (NYSE:TBI), historical trading data shows that trading volumes averaged 0.25 over the past 10 days and 164.31K over the past 3 months. The company’s latest data on shares outstanding shows there are 29.59 million shares.
The 5.85% of TrueBlue Inc’s shares are in the hands of company insiders while institutional holders own 96.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.86 million on 2025-02-28, giving us a short ratio of 4.86. The data shows that as of 2025-02-28 short interest in TrueBlue Inc (TBI) stood at 432.0 of shares outstanding, with shares short falling to 0.87 million registered in 2025-01-31. Current price change has pushed the stock -32.02% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TBI stock continues to rise going into the next quarter.
